38. The use of 1,25[α] dihydroxyvitamin D3 as a cryosensitizing agent in a murine prostate cancer model
✍ Scribed by Santucci, Kimberly L.; Snyder, Kristi K.; Baust, John M.; Van Buskirk, Robert G.; Mouraviev, Vladimir; Polascik, Thomas J.; Baust, John G.
- Book ID
- 122821274
- Publisher
- Elsevier Science
- Year
- 2013
- Tongue
- English
- Weight
- 55 KB
- Volume
- 66
- Category
- Article
- ISSN
- 0011-2240
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Five analogs of 1 alpha,25-dihydroxyvitamin D3 [1,25(OH)2D3] [1], 26,27-dimethyl-1 alpha,25-dihydroxyvitamin D3 [1,25(OH)2(Me)2D3] [2], 26,27-dimethyl-1 alpha,25-dihydroxyvitamin D3 [1,25(OH)2(Et)2D3] [3], 26,27-dipropyl-1 alpha,25-dihydroxyvitamin D3 [1,25(OH)2(Pr)2D3] [4], 26,27-dimethyl-24,24-dif
## Abstract 9__‐cis__‐Retinoic acid (9cRA) and 1α,25‐dihydroxyvitamin D~3~ (1,25D) show promise as potential chemopreventive agents. We examined 9cRA and 1,25D, alone and in combination, for their potential to inhibit carcinogen (NNK)‐induced lung carcinogenesis in A/J mice. A/J mice (__n__ = 14/gr